AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

FACTEUR IX

11 registrations across 2 African markets— 1 active

Markets with FACTEUR IX

Recent registrations

Brand / ProductMarketHolderStatusExpires
HAEMONINE 500 UI
Pdre p.prep.injectable / 100 UI/ml
🇹🇳TunisiaBIOTEST PHARMA GmbHexpiredApr 2015
BENEFIX 250 UI
Pdre p.prep.injectable / 250 UI
🇹🇳TunisiaPFIZER Limited UKexpiredSept 2014
BENEFIX 500 UI
Pdre p.prep.injectable / 500 UI
🇹🇳TunisiaPFIZER Limited UKexpiredSept 2014
BENEFIX 1000 UI
Pdre p.prep.injectable / 1000 UI
🇹🇳TunisiaPFIZER Limited UKexpiredSept 2014
BETAFACT
Pdre p.prep.injectable / 250 UI/ 5 ML
🇹🇳TunisiaLFB-BiomédicamentsexpiredAug 2013
AIMAFIX
Pdre p.prep.injectable / 500 UI/ 10 ml
🇹🇳TunisiaKEDRION S.p.AexpiredAug 2013
HAEMONINE 250 UI
Pdre p.prep.injectable / 50 UI/ml
🇹🇳TunisiaBIOTEST PHARMA GmbHexpiredAug 2013
IMMUNINE
Pdre p.prep.injectable / 600 UI
🇹🇳TunisiaBAXTER AG AutricheexpiredFeb 2010
BETAFACT
Pdre p.prep.injectable / 500 UI
🇹🇳TunisiaLFB-BiomédicamentsexpiredJun 1998
NANOTIV 500 UI
Pdre p.prep.injectable / 500 UI
🇹🇳TunisiaOCTAPHARMA ABexpiredMar 1998
FACTEUR IX DE COAGULATION HUMAIN-CNTS 50 UI/ML
POUDRE ET SOLVANT POUR SOLUTION INJECTABLE
🇲🇦Moroccoactive

FACTEUR IX in Africa — Regulatory Overview

FACTEUR IX is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 1 (9%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.